Dabigatran etexilate Completed Phase 2 Trials for Venous Thromboembolism (VTE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02170701BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery
NCT02170935Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement Surgery
NCT00844415Safety and Tolerability of Dabigatran Etexilate in Adolescents